Alexandre Fontayne received his PhD in Biological Science at the University of Paris Sud (France). He has more than 20 years of experience in R&D, including 17 years in the pharmaceutical industry working around drug design and the production of biologics, including ublituximab. Mr Fontayne is the co-author of 28 scientific articles and inventor of 12 patents. He contributes to the training of students and employees in drug design, chemistry manufacturing and control activities and subcontracting. Since 2021, Mr Fontayne has worked for Unither Pharmaceuticals as Chief Scientific Officer for biological products and is deeply involved in the development of the Euroject® device.
